ArticleJACC. CardioOncology2021

Effect of Tafamidis on Serum Transthyretin Levels in Non-Trial Patients With Transthyretin Amyloid Cardiomyopathy.

Rodney H Falk et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.